BET Bromodomain Inhibition Upregulates SIRT1 In Pancreatic β-Cells

被引：0
|
作者：
Lipinski, Rachel A. Jones
Wynia-Smith, Sarah
Nord, Joshua
Smith, Brian C.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-2131-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2131-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Identifying mechanisms of resistance to BET bromodomain inhibition.
    Centore, Richard C.
    Hatton, Charlie
    Bryant, Barbara
    Sims, Robert J., III
    CLINICAL CANCER RESEARCH, 2015, 21
  • [32] Inhibition of BET bromodomain improves anemia in APCmin mice
    Xiao, Yi
    Liu, Zhenzhen
    Liao, Chaonan
    Mao, Xiaoxiao
    Cai, Jinxing
    Xia, Ke
    Qi, Jun
    Huang, He
    Yang, Tianlun
    Duan, Qiong
    LEUKEMIA & LYMPHOMA, 2017, 58 (04) : 989 - 992
  • [33] Therapeutic resistance to BET bromodomain inhibition in prostate cancer
    Engelke, Carl G.
    Malik, Rohit
    Kregel, Steven
    Asangani, Irfan A.
    Wilder-Romans, Kari
    Jiang, Xia
    Cao, Xuhong
    Speers, Corey
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2017, 77
  • [34] Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
    Mao, Wendy
    Ghasemzadeh, Ali
    Freeman, Zachary T.
    Obradovic, Aleksandar
    Chaimowitz, Matthew G.
    Nirschl, Thomas R.
    McKiernan, Emily
    Yegnasubramanian, Srinivasan
    Drake, Charles G.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [35] INHIBITION OF SIRT1 IMPAIRS THE GROWTH OF HCC TUMOURS
    Portmann, S.
    Fahrner, R.
    Lechleiter, A.
    Overney, S.
    Tschan, M.
    Candinas, D.
    Stroka, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S123 - S124
  • [36] Selective BET bromodomain inhibition as an antifungal therapeutic strategy
    Mietton, Flore
    Ferri, Elena
    Champleboux, Morgane
    Zala, Ninon
    Maubon, Daniele
    Zhou, Yingsheng
    Harbut, Mike
    Spittler, Didier
    Garnaud, Cecile
    Courcon, Marie
    Chauvel, Murielle
    d'Enfert, Christophe
    Kashemirov, Boris A.
    Hull, Mitchell
    Cornet, Muriel
    McKenna, Charles E.
    Govin, Jerome
    Petosa, Carlo
    NATURE COMMUNICATIONS, 2017, 8
  • [37] BET BROMODOMAIN INHIBITION OF MYC-AMPLIFIED MEDULLOBLASTOMA
    Bandopadhayay, P.
    Nguyen, B.
    Masoud, S.
    Vue, N.
    Gholamin, S.
    Yu, F.
    Schubert, S.
    Bergthold, G.
    Mitra, S.
    Cheshire, S.
    Qi, J.
    Bradner, J. E.
    Kieran, M. W.
    Beroukhim, R.
    Cho, Y. J.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 36 - 36
  • [38] BET BROMODOMAIN INHIBITION OF MYC-AMPLIFIED MEDULLOBLASTOMA
    Bandopadhayay, Pratiti
    Nguyen, Brian
    Masoud, Sabran
    Vue, Nujsaubnusi
    Gholamin, Sharareh
    Yu, Furong
    Schubert, Simone
    Bergthold, Guillaume
    Mitra, Siddhartha
    Qi, Jun
    Bradner, James
    Kieran, Mark
    Beroukhim, Rameen
    Cho, Yoon-Jae
    NEURO-ONCOLOGY, 2013, 15 : 36 - 36
  • [39] Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition.
    Puissant, Alexandre
    Frumm, Stacey M.
    Alexe, Gabriela
    Bassii, Christopher F.
    Qi, Jun
    Chanthery, Yvan H.
    Nekritz, Erin A.
    Zeid, Rhamy
    Gustafson, W. Clay
    Greninger, Patricia
    Garnett, Matthew J.
    McDermott, Ultan
    Benes, Cyril H.
    Kung, Andrew L.
    Weiss, William A.
    Bradner, James E.
    Stegmaier, Kimberly
    CANCER RESEARCH, 2013, 73 (08)
  • [40] Inhibition of SIRT1 impairs growth and autophagy in HCC
    Portmann, Simone
    Schwarz, Christa
    Tschan, Mario
    Candinas, Daniel
    Stroka, Deborah
    SWISS MEDICAL WEEKLY, 2012, 142 : 6S - 6S
12345